Most Recent Articles about BPMC
Blueprint Medicines (BPMC) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? https://www.zacks.com/stock/news/2320079/blueprint-medicines-bpmc-forms-hammer-chart-pattern-time-for-bottom-fishing?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2320079 Aug 09, 2024 - After losing some value lately, a hammer chart pattern has been formed for Blueprint Medicines (BPMC), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Masimo (MASI) Q2 Earnings Beat Estimates, Gross Margin Up https://www.zacks.com/stock/news/2318310/masimo-masi-q2-earnings-beat-estimates-gross-margin-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2318310 Aug 07, 2024 - Strength in Healthcare revenues drive Masimo's (MASI) second-quarter results.
Blueprint Medicines (BPMC) Down Despite Q2 Earnings Beat https://www.zacks.com/stock/news/2315371/blueprint-medicines-bpmc-down-despite-q2-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2315371 Aug 02, 2024 - Blueprint Medicines' (BPMC) earnings and revenues surpass estimates in the second quarter of 2024. The company raises its product revenue guidance for 2024. Stock declines.